News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Integrated Biosystems Expands European Operations

10/19/2005 5:10:28 PM

NAPA, Calif., Nov. 10 /PRNewswire/ -- Integrated Biosystems, Inc. (IBI), the world's leading supplier of controlled freeze-thaw technology to the biopharmaceutical industry, today announced that a new customer support and applications laboratory has been opened in Aubagne, near Marseille, France.

The laboratory is located in the facilities of STEDIM with whom IBI has formed a strategic partnership to develop and commercialize its patented freeze-thaw technology incorporating disposable containers for use in the manufacturing of biopharmaceuticals. STEDIM is a global company with twenty-five years experience in the design and manufacture of single use plastic containers for the world's largest healthcare and pharmaceutical companies.

Although IBI has maintained a research and development operation in France to develop new products with STEDIM, the new laboratory, with increased staffing, will be the center for technical and applications support for the company's growing number of customers in Europe.

"Europe is a very important market for us," commented Richard Eagling, General Manager, Europe. "We see a lot of opportunity for growth. Our new facility is an essential component in providing excellent service and support for our growing customer base."

The new applications center complements IBI's existing commercial organization which is headquartered in Fribourg, Switzerland. The company already sells its controlled freeze-thaw technology to many of the large pharmaceutical manufacturers in Europe. The first product line, consisting of stainless steel vessels and thermal control units, sold under the CryoFin brand, was introduced about three years ago in Europe. The new Celsius product line, which will allow customers to perform their freeze-thaw operations using single use containers manufactured by STEDIM, is currently being launched worldwide. IBI's technology is already an integral part of the manufacturing process of many of the major biopharmaceutical products on the market today. More and more of these products are being manufactured in Europe to support the European healthcare needs. In addition, many of the large global pharmaceutical companies look to Europe for additional manufacturing capacity to meet the high growth projections of the biopharmaceutical industry.

As this market continues to experience rapid growth, IBI will be well positioned to provide the necessary technical support aimed at optimizing the efficiency of the biopharmaceutical industry's process development and manufacturing operations.

About Integrated Biosystems, Inc.

Integrated Biosystems, Inc. (IBI) is the world's leading supplier of patented technology and equipment for the controlled freezing, thawing and frozen storage of biopharmaceutical intermediates and final bulk drug substances. IBI's product portfolio includes freeze-thaw systems and related handling equipment for R&D, Pilot and Full-Scale Manufacturing. The technology has been used for over 10 years at leading Biotech and Biopharma contract manufacturers and is currently an integral part of the manufacture of a variety of leading biopharmaceuticals.

IBI is a private company headquartered in Napa, CA with European facilities in Fribourg (Switzerland) and Aubagne (France) and Engineering and Manufacturing operations in Springfield, MO.

For further information contact Richard Eagling, Vice-President Marketing and General Manager, Europe ( or go to


STEDIM is the world's leading designer and manufacturer of single-use, sterile plastic bag systems, replacing traditional glassware and stainless steel vessels for the manufacture and the packaging of medical and biopharmaceutical products. Developed since 1990, STEDIM's biotechnology and drug delivery operations provide all types of bag systems, answering the needs of biopharmaceutical laboratories and manufacturers for the development, manufacturing process, packaging and administration of therapeutic drugs, from Drug Discovery to Drug Delivery.

STEDIM is headquartered in Aubagne, with major companies, in Concord, CA, and more than 15 countries. STEDIM is listed on the Second Marche of the Euronext Paris S.A. (France Euroclear code : 5326).

Further information is available at

Integrated Biosystems, Inc.

CONTACT: Richard Eagling of Integrated Biosystems, Inc, +1-707-226-9300,ext. 237

Read at

comments powered by Disqus